# Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer

> **NCT00025532** · PHASE1 · WITHDRAWN · sponsor: **University of California, San Francisco**

## Conditions studied

- Colorectal Cancer
- Esophageal Cancer
- Gastric Cancer
- Pancreatic Cancer

## Interventions

- **OTHER:** iodine I 131 monoclonal antibody CC49-deltaCH2

## Key facts

- **NCT ID:** NCT00025532
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2001-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00025532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00025532, "Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00025532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*